324 related articles for article (PubMed ID: 10782657)
1. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Sweeney C; Gammon MD; Chow WH; Risch HA; Stanford JL; Hansten PD; Mayne ST; Schoenberg JB; Rotterdam H; Ahsan H; West AB; Dubrow R; Fraumeni JF; Blot WJ
Cancer Causes Control; 2000 Mar; 11(3):231-8. PubMed ID: 10782657
[TBL] [Abstract][Full Text] [Related]
2. Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.
Vaughan TL; Farrow DC; Hansten PD; Chow WH; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Rotterdam H; Dubrow R; Ahsan H; West AB; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):749-56. PubMed ID: 9752982
[TBL] [Abstract][Full Text] [Related]
3. Population attributable risks of esophageal and gastric cancers.
Engel LS; Chow WH; Vaughan TL; Gammon MD; Risch HA; Stanford JL; Schoenberg JB; Mayne ST; Dubrow R; Rotterdam H; West AB; Blaser M; Blot WJ; Gail MH; Fraumeni JF
J Natl Cancer Inst; 2003 Sep; 95(18):1404-13. PubMed ID: 13130116
[TBL] [Abstract][Full Text] [Related]
4. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia.
Chow WH; Finkle WD; McLaughlin JK; Frankl H; Ziel HK; Fraumeni JF
JAMA; 1995 Aug; 274(6):474-7. PubMed ID: 7629956
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Lagergren J; Bergström R; Lindgren A; Nyrén O
N Engl J Med; 1999 Mar; 340(11):825-31. PubMed ID: 10080844
[TBL] [Abstract][Full Text] [Related]
6. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
Wu AH; Tseng CC; Bernstein L
Cancer; 2003 Sep; 98(5):940-8. PubMed ID: 12942560
[TBL] [Abstract][Full Text] [Related]
7. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma.
Lagergren J; Bergström R; Adami HO; Nyrén O
Ann Intern Med; 2000 Aug; 133(3):165-75. PubMed ID: 10906830
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia.
Chow WH; Blot WJ; Vaughan TL; Risch HA; Gammon MD; Stanford JL; Dubrow R; Schoenberg JB; Mayne ST; Farrow DC; Ahsan H; West AB; Rotterdam H; Niwa S; Fraumeni JF
J Natl Cancer Inst; 1998 Jan; 90(2):150-5. PubMed ID: 9450576
[TBL] [Abstract][Full Text] [Related]
10. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.
García Rodríguez LA; Lagergren J; Lindblad M
Gut; 2006 Nov; 55(11):1538-44. PubMed ID: 16785284
[TBL] [Abstract][Full Text] [Related]
11. Nutrient intake and risk of subtypes of esophageal and gastric cancer.
Mayne ST; Risch HA; Dubrow R; Chow WH; Gammon MD; Vaughan TL; Farrow DC; Schoenberg JB; Stanford JL; Ahsan H; West AB; Rotterdam H; Blot WJ; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1055-62. PubMed ID: 11588131
[TBL] [Abstract][Full Text] [Related]
12. Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden.
Bahmanyar S; Ye W
Nutr Cancer; 2006; 54(2):171-8. PubMed ID: 16898861
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
Green JA; Amaro R; Barkin JS
Dig Dis Sci; 2000 Dec; 45(12):2367-8. PubMed ID: 11258559
[TBL] [Abstract][Full Text] [Related]
14. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.
Vaughan TL; Davis S; Kristal A; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1995 Mar; 4(2):85-92. PubMed ID: 7742727
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and esophageal and gastric cancer.
Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
[TBL] [Abstract][Full Text] [Related]
16. Use of tight belts and risk of esophageal adenocarcinoma.
Lagergren J; Jansson C
Int J Cancer; 2006 Nov; 119(10):2464-6. PubMed ID: 16894563
[TBL] [Abstract][Full Text] [Related]
17. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas.
Corley DA; Kubo A; Zhao W
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):352-8. PubMed ID: 18268119
[TBL] [Abstract][Full Text] [Related]
18. Diet and lifestyle factors and risk of subtypes of esophageal and gastric cancers: classification tree analysis.
Navarro Silvera SA; Mayne ST; Gammon MD; Vaughan TL; Chow WH; Dubin JA; Dubrow R; Stanford JL; West AB; Rotterdam H; Blot WJ; Risch HA
Ann Epidemiol; 2014 Jan; 24(1):50-7. PubMed ID: 24239095
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes.
Freedman ND; Abnet CC; Leitzmann MF; Mouw T; Subar AF; Hollenbeck AR; Schatzkin A
Am J Epidemiol; 2007 Jun; 165(12):1424-33. PubMed ID: 17420181
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.
Figueroa JD; Terry MB; Gammon MD; Vaughan TL; Risch HA; Zhang FF; Kleiner DE; Bennett WP; Howe CL; Dubrow R; Mayne ST; Fraumeni JF; Chow WH
Cancer Causes Control; 2009 Apr; 20(3):361-8. PubMed ID: 18989634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
